Extrachromosomal DNA and cancer: function, formation, and clinical implications

Extrachromosomal DNA (ecDNA) is a circular, double-stranded DNA molecule distinct from chromosomal DNA, primarily found in cancer cells as a subtype of extrachromosomal circular DNA (eccDNA). Unlike eccDNAs found in normal cells, cancer-associated ecDNAs are large, clonal, and carry complete oncogenes. These ecDNAs are increasingly recognized as crucial drivers of cancer pathogenesis, contributing significantly to the evolution of tumor heterogeneity and the acquisition of therapeutic resistance through mechanisms such as high-level gene amplification and altered gene regulation. Historically, the understanding of these mobile genetic elements in cancer has been limited. This review synthesizes current knowledge on ecDNA’s structural and functional features, formation mechanisms and roles in cancer initiation, progression and therapeutic resistance. Moreover, we summarize five emerging therapeutic approaches that target ecDNA to inform future cancer research and precision medicine.

Authors

Institutions

Publication Details

Journal
Journal of Experimental & Clinical Cancer Research
Published
2026-01-19
DOI
https://doi.org/10.1186/s13046-026-03639-0
Primary Topic
Cancer Genomics and Diagnostics
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Extrachromosomal DNA and cancer: function, formation, and clinical implications

Rui Rui, Liqun Zhou, Yanqing Gong, Rui Zhang et al.
Journal of Experimental & Clinical Cancer Research
Cancer Genomics and Diagnostics
article

Extrachromosomal DNA and cancer: function, formation, and clinical implications

Rui Rui, Liqun Zhou, Yanqing Gong, Rui Zhang, Yucai Wu, Tai Tian, Xuesong Li, Shiming He
article en

Abstract

Extrachromosomal DNA (ecDNA) is a circular, double-stranded DNA molecule distinct from chromosomal DNA, primarily found in cancer cells as a subtype of extrachromosomal circular DNA (eccDNA). Unlike eccDNAs found in normal cells, cancer-associated ecDNAs are large, clonal, and carry complete oncogenes. These ecDNAs are increasingly recognized as crucial drivers of cancer pathogenesis, contributing significantly to the evolution of tumor heterogeneity and the acquisition of therapeutic resistance through mechanisms such as high-level gene amplification and altered gene regulation. Historically, the understanding of these mobile genetic elements in cancer has been limited. This review synthesizes current knowledge on ecDNA’s structural and functional features, formation mechanisms and roles in cancer initiation, progression and therapeutic resistance. Moreover, we summarize five emerging therapeutic approaches that target ecDNA to inform future cancer research and precision medicine.

Journal of Experimental & Clinical Cancer ResearchVol. 45(1)
Sun Yat-sen University (CN), Peking University (CN), National Clinical Research Center for Digestive Diseases (CN), Peking University First Hospital (CN), China National Building Materials Group (China) (CN)
Good health and well-being
Openalex Percentile: Top 85%
Cancer Genomics and Diagnostics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Extrachromosomal DNA and cancer: function, formation, and clinical implications — Rui Rui, Liqun Zhou, et al. · Journal of Experimental & Clinical Cancer Research (2026) | TGRS Research Map | TGRS